These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8532615)

  • 21. 5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats.
    Cervo L; Samanin R
    Pharmacol Biochem Behav; 1995 Dec; 52(4):671-6. PubMed ID: 8587903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs.
    De Vry J; Benz U; Schreiber R; Traber J
    Eur J Pharmacol; 1993 Nov; 249(3):331-9. PubMed ID: 7904565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasonic vocalizations in rat pups: effects of serotonergic ligands.
    Olivier B; Molewijk HE; van der Heyden JA; van Oorschot R; Ronken E; Mos J; Miczek KA
    Neurosci Biobehav Rev; 1998; 23(2):215-27. PubMed ID: 9884114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of ipsapirone and 8-OH-DPAT on exploratory behavior in hamsters (Mesocricetus auratus): effects of antagonists and p-CPA.
    Fernández-Guasti A; López-Rubalcava C
    Pharmacol Biochem Behav; 1995 Mar; 50(3):375-82. PubMed ID: 7617675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
    Njung'e K; Handley SL
    Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test.
    Schreiber R; Melon C; De Vry J
    Psychopharmacology (Berl); 1998 Feb; 135(4):383-91. PubMed ID: 9539263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
    Sharp T; McQuade R; Bramwell S; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):817-27. PubMed ID: 9259011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in the isolation-induced social behavioural deficit by agonists at 5-HT1A receptors.
    Francès H; Khidichian F; Monier C
    Neuropharmacology; 1990 Feb; 29(2):103-7. PubMed ID: 1970424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice.
    Stork O; Welzl H; Wotjak CT; Hoyer D; Delling M; Cremer H; Schachner M
    J Neurobiol; 1999 Sep; 40(3):343-55. PubMed ID: 10440734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.
    Wesołowska A; Paluchowska MH; Gołembiowska K; Chojnacka-Wójcik E
    J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.